Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver

CYP2B10 is responsible for metabolism and detoxification of many clinical drugs. Here, we aimed to investigate a potential role of Period 2 (PER2) in regulating expression of hepatic CYP2B10. Regulatory effects of PER2 on hepatic expression of CYP2B10 and other enzymes were determined using Per2-def...

Full description

Bibliographic Details
Main Authors: MengLin Chen, Min Chen, Danyi Lu, Yi Wang, Li Zhang, Zhigang Wang, Baojian Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.764124/full
_version_ 1818401907588202496
author MengLin Chen
MengLin Chen
Min Chen
Min Chen
Danyi Lu
Yi Wang
Yi Wang
Li Zhang
Li Zhang
Zhigang Wang
Baojian Wu
author_facet MengLin Chen
MengLin Chen
Min Chen
Min Chen
Danyi Lu
Yi Wang
Yi Wang
Li Zhang
Li Zhang
Zhigang Wang
Baojian Wu
author_sort MengLin Chen
collection DOAJ
description CYP2B10 is responsible for metabolism and detoxification of many clinical drugs. Here, we aimed to investigate a potential role of Period 2 (PER2) in regulating expression of hepatic CYP2B10. Regulatory effects of PER2 on hepatic expression of CYP2B10 and other enzymes were determined using Per2-deficient mice with exons 4-6 deleted (named Per2Del4-6 mice). In vitro and in vivo metabolic activities of CYP2B10 were probed using cyclophosphamide (CPA) as a specific substrate. Regulatory mechanism was investigated using luciferase reporter assays. Genotyping and Western blotting demonstrated loss of wild-type Per2 transcript and markedly reduced PER2 protein in Per2Del4-6 mice. Hepatic expression of a plenty of drug-metabolizing genes (including Cyp2a4/2a5, Cyp2b10, Ugt1a1, Ugt1a9, Ugt2b36, Sult1a1 and Sult1e1) were altered (and majority were down-regulated) in Per2Del4-6 mice. Of note, Cyp2b10, Ugt1a9 and Sult1a1 were three genes considerably affected with reduced expression. Decreased expression of CYP2B10 was translated to reduced metabolism and altered pharmacokinetics of CPA as well as attenuated CPA hepatotoxicity in Per2Del4-6 mice. Positive regulation of CYP2B10 by PER2 was further confirmed in both Hepa-1c1c7 and AML-12 cells. Based on luciferase reporter assays, it was shown that PER2 regulated Cyp2b10 transcription in a REV-ERBα-dependent manner. REV-ERBα was negatively regulated by PER2 (increased REV-ERBα expression in Per2Del4-6 mice) and itself was also a repressor of CYP2B10. In conclusion, PER2 positively regulates CYP2B10 expression and activity in mouse liver through inhibiting its repressor REV-ERBα.
first_indexed 2024-12-14T07:59:56Z
format Article
id doaj.art-014a37401264465bb354052a0ed7740f
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-14T07:59:56Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-014a37401264465bb354052a0ed7740f2022-12-21T23:10:27ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-11-011210.3389/fphar.2021.764124764124Period 2 Regulates CYP2B10 Expression and Activity in Mouse LiverMengLin Chen0MengLin Chen1Min Chen2Min Chen3Danyi Lu4Yi Wang5Yi Wang6Li Zhang7Li Zhang8Zhigang Wang9Baojian Wu10College of Pharmacy, Jinan University, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaCollege of Pharmacy, Jinan University, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaCollege of Pharmacy, Jinan University, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaCollege of Pharmacy, Jinan University, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaDepartment of Intensive Care Unit, First Affiliated Hospital of Jinan University, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaCYP2B10 is responsible for metabolism and detoxification of many clinical drugs. Here, we aimed to investigate a potential role of Period 2 (PER2) in regulating expression of hepatic CYP2B10. Regulatory effects of PER2 on hepatic expression of CYP2B10 and other enzymes were determined using Per2-deficient mice with exons 4-6 deleted (named Per2Del4-6 mice). In vitro and in vivo metabolic activities of CYP2B10 were probed using cyclophosphamide (CPA) as a specific substrate. Regulatory mechanism was investigated using luciferase reporter assays. Genotyping and Western blotting demonstrated loss of wild-type Per2 transcript and markedly reduced PER2 protein in Per2Del4-6 mice. Hepatic expression of a plenty of drug-metabolizing genes (including Cyp2a4/2a5, Cyp2b10, Ugt1a1, Ugt1a9, Ugt2b36, Sult1a1 and Sult1e1) were altered (and majority were down-regulated) in Per2Del4-6 mice. Of note, Cyp2b10, Ugt1a9 and Sult1a1 were three genes considerably affected with reduced expression. Decreased expression of CYP2B10 was translated to reduced metabolism and altered pharmacokinetics of CPA as well as attenuated CPA hepatotoxicity in Per2Del4-6 mice. Positive regulation of CYP2B10 by PER2 was further confirmed in both Hepa-1c1c7 and AML-12 cells. Based on luciferase reporter assays, it was shown that PER2 regulated Cyp2b10 transcription in a REV-ERBα-dependent manner. REV-ERBα was negatively regulated by PER2 (increased REV-ERBα expression in Per2Del4-6 mice) and itself was also a repressor of CYP2B10. In conclusion, PER2 positively regulates CYP2B10 expression and activity in mouse liver through inhibiting its repressor REV-ERBα.https://www.frontiersin.org/articles/10.3389/fphar.2021.764124/fullPER2Cyp2b10REV-ERBαcyclophosphamidedrug metabolism
spellingShingle MengLin Chen
MengLin Chen
Min Chen
Min Chen
Danyi Lu
Yi Wang
Yi Wang
Li Zhang
Li Zhang
Zhigang Wang
Baojian Wu
Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver
Frontiers in Pharmacology
PER2
Cyp2b10
REV-ERBα
cyclophosphamide
drug metabolism
title Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver
title_full Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver
title_fullStr Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver
title_full_unstemmed Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver
title_short Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver
title_sort period 2 regulates cyp2b10 expression and activity in mouse liver
topic PER2
Cyp2b10
REV-ERBα
cyclophosphamide
drug metabolism
url https://www.frontiersin.org/articles/10.3389/fphar.2021.764124/full
work_keys_str_mv AT menglinchen period2regulatescyp2b10expressionandactivityinmouseliver
AT menglinchen period2regulatescyp2b10expressionandactivityinmouseliver
AT minchen period2regulatescyp2b10expressionandactivityinmouseliver
AT minchen period2regulatescyp2b10expressionandactivityinmouseliver
AT danyilu period2regulatescyp2b10expressionandactivityinmouseliver
AT yiwang period2regulatescyp2b10expressionandactivityinmouseliver
AT yiwang period2regulatescyp2b10expressionandactivityinmouseliver
AT lizhang period2regulatescyp2b10expressionandactivityinmouseliver
AT lizhang period2regulatescyp2b10expressionandactivityinmouseliver
AT zhigangwang period2regulatescyp2b10expressionandactivityinmouseliver
AT baojianwu period2regulatescyp2b10expressionandactivityinmouseliver